Studies on antiviral resistant SARS-CoV-2 Mpro mutants

por Esler, Morgan A., Moghadasi, Arad, Harris, Reuben S., Aihara, Hideki
Publicado 2023

Developing inhibitors of the SARS-CoV-2 main protease

por Seitz, Christian, Markota, Vedran, Sztain-Pedone, Terra, Esler, Morgan, Moghadasi, Arad, Kennelly, Samantha, Demir, Ozlem, Aihara, Hideki, Harki, Daniel A., Harris, Reuben, McCammon, J. Andrew, Amaro, Rommie E.
Publicado 2022

Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors

por Moghadasi, Seyed Arad, Heilmann, Emmanuel, Khalil, Ahmed Magdy, Nnabuife, Christina, Kearns, Fiona L., Ye, Chengjin, Moraes, Sofia N., Costacurta, Francesco, Esler, Morgan A., Aihara, Hideki, von Laer, Dorothee, Martinez-Sobrido, Luis, Palzkill, Timothy, Amaro, Rommie E., Harris, Reuben S.
Publicado 2023

Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors

por Moghadasi, Seyed Arad, Heilmann, Emmanuel, Khalil, Ahmed Magdy, Nnabuife, Christina, Kearns, Fiona L., Ye, Chengjin, Moraes, Sofia N., Costacurta, Francesco, Esler, Morgan A., Aihara, Hideki, von Laer, Dorothee, Martinez-Sobrido, Luis, Palzkill, Timothy, Amaro, Rommie E., Harris, Reuben S.
Publicado 2022

Gain-of-Signal Assays for Probing Inhibition of SARS-CoV-2 M(pro)/3CL(pro) in Living Cells

por Moghadasi, Seyed Arad, Esler, Morgan A., Otsuka, Yuka, Becker, Jordan T., Moraes, Sofia N., Anderson, Constance B., Chamakuri, Srinivas, Belica, Christopher, Wick, Chloe, Harki, Daniel A., Young, Damian W., Scampavia, Louis, Spicer, Timothy P., Shi, Ke, Aihara, Hideki, Brown, William L., Harris, Reuben S.
Publicado 2022